Transgene Biotek Ltd Declares Unaudited Financial Results

Transgene Biotek Ltd announced its Unaudited Standalone and Consolidated Financial Results for the quarter and half-year ended September 30, 2026. The Board of Directors also approved the Notice for the 36th Annual General Meeting (AGM) scheduled for December 30, 2026, and the Directors' Report for FY 2025-26. The company also approved the re-appointment of Dr. K. Koteswara Rao as Chairman and Managing Director for a further period of one year, subject to shareholder approval. The Register of Members and Share Transfer Books will be closed from December 24 to December 30, 2026, for the AGM.